Literature DB >> 12210999

Structural parameterization of the binding enthalpy of small ligands.

Irene Luque1, Ernesto Freire.   

Abstract

A major goal in ligand and drug design is the optimization of the binding affinity of selected lead molecules. However, the binding affinity is defined by the free energy of binding, which, in turn, is determined by the enthalpy and entropy changes. Because the binding enthalpy is the term that predominantly reflects the strength of the interactions of the ligand with its target relative to those with the solvent, it is desirable to develop ways of predicting enthalpy changes from structural considerations. The application of structure/enthalpy correlations derived from protein stability data has yielded inconsistent results when applied to small ligands of pharmaceutical interest (MW < 800). Here we present a first attempt at an empirical parameterization of the binding enthalpy for small ligands in terms of structural information. We find that at least three terms need to be considered: (1) the intrinsic enthalpy change that reflects the nature of the interactions between ligand, target, and solvent; (2) the enthalpy associated with any possible conformational change in the protein or ligand upon binding; and, (3) the enthalpy associated with protonation/deprotonation events, if present. As in the case of protein stability, the intrinsic binding enthalpy scales with changes in solvent accessible surface areas. However, an accurate estimation of the intrinsic binding enthalpy requires explicit consideration of long-lived water molecules at the binding interface. The best statistical structure/enthalpy correlation is obtained when buried water molecules within 5-7 A of the ligand are included in the calculations. For all seven protein systems considered (HIV-1 protease, dihydrodipicolinate reductase, Rnase T1, streptavidin, pp60c-Src SH2 domain, Hsp90 molecular chaperone, and bovine beta-trypsin) the binding enthalpy of 25 small molecular weight peptide and nonpeptide ligands can be accounted for with a standard error of +/-0.3 kcal x mol(-1). Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12210999     DOI: 10.1002/prot.10208

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  26 in total

1.  Thermodynamic Proxies to Compensate for Biases in Drug Discovery Methods.

Authors:  Sean Ekins; Nadia K Litterman; Christopher A Lipinski; Barry A Bunin
Journal:  Pharm Res       Date:  2015-08-27       Impact factor: 4.200

2.  A combination of docking, QM/MM methods, and MD simulation for binding affinity estimation of metalloprotein ligands.

Authors:  Akash Khandelwal; Viera Lukacova; Dogan Comez; Daniel M Kroll; Soumyendu Raha; Stefan Balaz
Journal:  J Med Chem       Date:  2005-08-25       Impact factor: 7.446

Review 3.  Scoring functions--the first 100 years.

Authors:  Jeremy R H Tame
Journal:  J Comput Aided Mol Des       Date:  2005-06       Impact factor: 3.686

4.  Identification and structural characterization of I84C and I84A mutations that are associated with high-level resistance to human immunodeficiency virus protease inhibitors and impair viral replication.

Authors:  Hongmei Mo; Neil Parkin; Kent D Stewart; Liangjun Lu; Tatyana Dekhtyar; Dale J Kempf; Akhteruzzaman Molla
Journal:  Antimicrob Agents Chemother       Date:  2006-11-13       Impact factor: 5.191

5.  Role of interfacial water molecules in proline-rich ligand recognition by the Src homology 3 domain of Abl.

Authors:  Andres Palencia; Ana Camara-Artigas; M Teresa Pisabarro; Jose C Martinez; Irene Luque
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

Review 6.  Adding calorimetric data to decision making in lead discovery: a hot tip.

Authors:  John E Ladbury; Gerhard Klebe; Ernesto Freire
Journal:  Nat Rev Drug Discov       Date:  2009-12-04       Impact factor: 84.694

7.  How much binding affinity can be gained by filling a cavity?

Authors:  Yuko Kawasaki; Eduardo E Chufan; Virginie Lafont; Koushi Hidaka; Yoshiaki Kiso; L Mario Amzel; Ernesto Freire
Journal:  Chem Biol Drug Des       Date:  2009-12-17       Impact factor: 2.817

8.  A solvated ligand rotamer approach and its application in computational protein design.

Authors:  Xiaoqiang Huang; Ji Yang; Yushan Zhu
Journal:  J Mol Model       Date:  2012-11-29       Impact factor: 1.810

9.  Binding thermodynamics of the N-terminal peptide of the CCR5 coreceptor to HIV-1 envelope glycoprotein gp120.

Authors:  Evan T Brower; Arne Schön; Jeffrey C Klein; Ernesto Freire
Journal:  Biochemistry       Date:  2009-02-03       Impact factor: 3.162

10.  Dual-inhibitors of STAT5 and STAT3: studies from molecular docking and molecular dynamics simulations.

Authors:  Shengjuan Shao; Rilei Yu; Yanqing Yu; Yanni Li
Journal:  J Mol Model       Date:  2014-08-07       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.